Rhythm Pharmaceuticals Inc (RYTM)

NASDAQ · Biotechnology

116.34
+0.90 (+0.78%)
Updated Aug 18, 5:53 PM ET
AI Rating
Buy
Overall Score
69
Trend
75
Momentum
80
Risk
44

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 20, 2026 120 sessions Aug 14, 2026

AI Analysis

Rhythm Pharmaceuticals Inc is trading at $116.34, up 0.78% on the session. The 50 day average sits at $103.87 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 60.4, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $105.52 with resistance near $115.92, so that band frames the current range. Average daily movement is roughly $5.08, or about 4.4% of the share price, which is what any stop placement has to allow for. The overall health score of 69 out of 100 combines a trend score of 75, momentum of 80 and a risk score of 44.

Technical indicators

RSI (14)
60.4
strong
MACD
3.110
bullish crossover
SMA 20
108.61
SMA 50
103.87
SMA 200
--
unknown
ATR (14)
5.08
avg daily range
Support
105.52
Resistance
115.92
Volume vs 20d
0.46x
below average
Volatility
45.4%
annualised
1 month
+5.02%
3 months
+26.47%

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.